In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines

[1]  D. Machin,et al.  Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. , 1999, Lancet.

[2]  W. Lau,et al.  Internal radiation therapy for patients with primary or metastatic hepatic cancer , 1998, Cancer.

[3]  M. Winslet,et al.  Quantification of uptake and retention of iodised oil (Lipiodol) in primary and secondary hepatic malignancy. , 1997 .

[4]  B. Davidson,et al.  Human liver cancer cells and endothelial cells incorporate iodised oil. , 1996, British Journal of Cancer.

[5]  C. Chi,et al.  I-131-lipiodol cytotoxicity in hepatoma cells. , 1994, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[6]  S. Beningfield,et al.  Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. , 1993, Gut.

[7]  Andrew J.W. Hilson,et al.  Ablation of recurrent primary liver cancer using 131I-lipiodol. , 1991, Postgraduate medical journal.

[8]  M. Doffoel,et al.  Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients , 1991, Hepatology.

[9]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[10]  Y. Deugnier,et al.  Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. , 1988, Radiology.

[11]  J. Raoul,et al.  Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. , 1988, Radiology.

[12]  E. Jaffe,et al.  Cell biology of endothelial cells. , 1987, Human pathology.

[13]  S. Tashiro,et al.  Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium , 1984, Cancer.

[14]  S. Tashiro,et al.  Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer , 1983, Cancer.

[15]  M. Friedman.  Primary hepatocellular cancer--present results and future prospects. , 1983, International journal of radiation oncology, biology, physics.

[16]  S. Tashiro,et al.  Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. , 1983, European journal of cancer & clinical oncology.

[17]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[18]  A. Leibovitz,et al.  Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.

[19]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[20]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.